Parexel shut down a San Diego office back in April, and three workers were axed while 37 others were offered work-from-home jobs.
This happened because there wasn’t enough use of the space. The company explained to FierceCRO: “In April 2019, Parexel closed our physical office in San Diego based on a review that showed low employee utilization of the available space over an extended period of time.
“Parexel provided our 37-local office-based employees flexible work-from-home arrangements to maintain our local presence while aligning our practices more closely with how our employees work today. A small number of roles, specifically our local Facilities and IT support, were eliminated based on the office closure.”
FREE DAILY NEWSLETTER
Like this story? Subscribe to FierceBiotech!
Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.
The closure was first made public in a recent WARN notice from California.
RELATED: Parexel nabs high-profile former FDA staffers, beefing up its regulatory offerings
This comes after fellow biopharma services company and rival Charles River Laboratories made a similar decision, cutting 24 employees from its San Diego site earlier this year. This also came out of a WARN notice, with the cuts confirmed to FierceCRO back in April, and staffers were relocated to a different site.